Skip to main content
Premium Trial:

Request an Annual Quote

Chembio Publishes Positive Data on Dual Path Platform Test for Syphilis

Premium

Chembio Diagnostics has published a study demonstrating the utility of its antibody-based Dual Path Platform point-of-care test for syphilis.

Published last month in the online edition of Clinical Infectious Diseases, the study used the Dual Path test to detect antibodies linked to syphilis in whole blood, fingerprick blood, and blood plasma samples. It found that the test could detect these antibodies with sensitivities of 96.7 percent for whole blood, 96.4 percent for fingerprick blood, and 94.6 percent for blood plasma and specificities of 99.3 percent, 99.1 percent, and 99.6 percent, respectively.

The study was supported by the Rapid Syphilis Test Introduction Project through a grant from the Bill & Melinda Gates Foundation and examined 3,134 specimens from a total of 1,323 individuals at six sites across China.

The Dual Path Platform detects levels of both non-treponemal antibodies, to screen for infection, and treponemal antibodies, to confirm that the infection is active, which allows clinicians to distinguish between active and past, or previously treated, cases.

According to Lawrence Siebert, CEO of Chembio, the company plans to use the data from the study to support a 510(k) submission for the test to the US Food & Drug Administration. It hopes to make that submission by the middle of 2013, he said in a statement.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.